Skip to content
DataLookout
Menu

PRODIABNCT07062224

Effect of a Probiotic Supplement on Gut Microbiota and Glycemic Control in Patients With Type 1 Diabetes (PRODIAB)

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 13 words Show 9 more changesShow less
    • Completed without a posted recruiting period
    • Final enrollment: 54 participants (planned 80)
    • Primary completion date changed from estimate of Nov 2025 to Jun 30, 2025
    • Study completion date changed from estimate of Dec 2025 to Dec 20, 2025
    • Start date changed from estimate of Sep 2025 to Feb 1, 2025
    • Interventions: Placebo Gel (Dietary Supplement), Probiotic/Prebiotic Supplement (Dietary Supplement) to Placebo Gel (Dietary Supplement), Probiotic/Prebiotic Supplement (Dietary Supplement)
    • Secondary endpoints: details revised at 8 of 11 entries
    • Site contact updated
    • Publications: details revised at 2 of 2 entries
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Change in gut microbiota composition
Timeframe: Baseline and 98 days post-intervention

Secondary (11)

Change in fasting glucose [Time Frame: Day 1 and Day 98]
Change in HbA1c [Time Frame: Day 1 and Day 98]
Change in fasting insulin [Time Frame: Day 1 and Day 98]
Change in HOMA-IR index [Time Frame: Day 1 and Day 98]
Change in time in range (70-180 mg/dL) [Time Frame: 3 months]
Show 6 moreShow less
Change in time above range (>180 mg/dL) [Time Frame: 3 months]
Change in time below range (<70 mg/dL) [Time Frame: 3 months]
Change in mean glucose [Time Frame: 3 months]
Change in glucose variability [Time Frame: 3 months]
Change in plasma zonulin levels [Time Frame: Day 1 and Day 98]
Change in fecal calprotectin levels [Time Frame: Day 1 and Day 98]

Arms and interventions

Type 1 Diabetes - SupplementExperimental

Participants with type 1 diabetes mellitus will receive a daily 10 mL gel supplement containing 4000 mg of inulin and 1000 mg of tyndallized probiotics for approximately 98 days. The supplement is designed to modulate gut microbiota and improve glycemic control.

Type 1 Diabetes - PlaceboExperimental

Participants with type 1 diabetes mellitus will receive a daily 10 mL placebo gel without active ingredients for approximately 98 days. The placebo is organoleptically identical to the supplement to maintain blinding.

Healthy Controls - SupplementExperimental

Healthy participants will receive a daily 10 mL gel supplement containing 4000 mg of inulin and 1000 mg of tyndallized probiotics for approximately 98 days. This arm allows comparison of microbiota and metabolic responses between diabetic and non-diabetic individuals.

Healthy Controls - PlaceboExperimental

Healthy participants will receive a daily 10 mL placebo gel without active ingredients for approximately 98 days. The placebo is identical in appearance and flavor to the active supplement.

Dietary supplements: Probiotic/Prebiotic Supplement, Placebo Gel

Sites

1 site in 1 country

  • UCAM San Antonio Catholic University of MurciaMurcia, Murcia, Spain